A carregar...
Birth Outcomes for Pregnant Women with HIV Using Tenofovir–Emtricitabine
BACKGROUND: In a previous trial of antiretroviral therapy (ART) involving pregnant women with human immunodeficiency virus (HIV) infection, those randomly assigned to receive tenofovir, emtricitabine, and ritonavir-boosted lopinavir (TDF–FTC–LPV/r) had infants at greater risk for very premature birt...
Na minha lista:
| Publicado no: | N Engl J Med |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5984044/ https://ncbi.nlm.nih.gov/pubmed/29694825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1701666 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|